The next generation, THERAKOS™ CELLEX® Photopheresis System incorporates innovative and advanced technologies, providing a new level of patient-focused care.



  • Single, integrated, closed system
  • Reduced risk of infection, cross-contamination, and reinfusion errors
  • Shorter treatment times (halved from 3 hours to 1.5 hours)


Manufacturer's site


  • CELLEX® Photopheresis System

    CELLEX® Photopheresis System

    THERAKOS® CELLEX® Photopheresis System, is the world’s only approved, fully-integrated system for administering autologous immune cell therapy through extracorporeal photopheresis (ECP).

    Read More